Herantis Pharma to Participate in the Upcoming Virtual Conference
Herantis Pharma Plc, Press Release, 28 May 2021 at 8:00 EET Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced that Dr. Craig Cook, Chief Executive Officer, will be holding a digital company presentation at the following virtual investor conference. Event Details: Redeye Investor Forum Online Date: 2 June 2021 Presentation Time: 10:50 CEST / 11:50 EEST The presentation will be available via a digital library, which is accessible to event participants only. Here you will find the registration